1. Home
  2. GBIO vs IZM Comparison

GBIO vs IZM Comparison

Compare GBIO & IZM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GBIO
  • IZM
  • Stock Information
  • Founded
  • GBIO 2016
  • IZM 2011
  • Country
  • GBIO United States
  • IZM China
  • Employees
  • GBIO N/A
  • IZM N/A
  • Industry
  • GBIO Biotechnology: Pharmaceutical Preparations
  • IZM Consumer Electronics/Video Chains
  • Sector
  • GBIO Health Care
  • IZM Consumer Discretionary
  • Exchange
  • GBIO Nasdaq
  • IZM Nasdaq
  • Market Cap
  • GBIO 29.2M
  • IZM 28.7M
  • IPO Year
  • GBIO 2020
  • IZM 2023
  • Fundamental
  • Price
  • GBIO $0.39
  • IZM $2.58
  • Analyst Decision
  • GBIO Strong Buy
  • IZM
  • Analyst Count
  • GBIO 4
  • IZM 0
  • Target Price
  • GBIO $7.33
  • IZM N/A
  • AVG Volume (30 Days)
  • GBIO 1.1M
  • IZM 31.4K
  • Earning Date
  • GBIO 08-06-2025
  • IZM 07-25-2025
  • Dividend Yield
  • GBIO N/A
  • IZM N/A
  • EPS Growth
  • GBIO N/A
  • IZM N/A
  • EPS
  • GBIO N/A
  • IZM N/A
  • Revenue
  • GBIO $24,556,000.00
  • IZM $180,553,977.00
  • Revenue This Year
  • GBIO N/A
  • IZM N/A
  • Revenue Next Year
  • GBIO N/A
  • IZM N/A
  • P/E Ratio
  • GBIO N/A
  • IZM N/A
  • Revenue Growth
  • GBIO 146.47
  • IZM N/A
  • 52 Week Low
  • GBIO $0.30
  • IZM $1.18
  • 52 Week High
  • GBIO $3.65
  • IZM $3.19
  • Technical
  • Relative Strength Index (RSI)
  • GBIO 52.02
  • IZM 59.08
  • Support Level
  • GBIO $0.32
  • IZM $2.50
  • Resistance Level
  • GBIO $0.36
  • IZM $2.74
  • Average True Range (ATR)
  • GBIO 0.03
  • IZM 0.10
  • MACD
  • GBIO 0.00
  • IZM -0.00
  • Stochastic Oscillator
  • GBIO 81.00
  • IZM 73.68

About GBIO Generation Bio Co.

Generation Bio Co is a genetics medicine company focused on creating gene therapies to provide durable and redosable treatments for patients suffering from rare and untreated diseases. The company focuses on liver and retina-related diseases. It is developing two distinct and complementary platforms that It believes will enable highly differentiated therapeutic applications. Its first platform is a potent, highly selective ctLNP delivery system for nucleic acids, which is designed to avoid off-target clearance by the liver and spleen, enabling ctLNPs to persist in systemic circulation and allowing for highly selective and potent ligand-driven targeting to specific tissues and cell types. Its second platform is its novel iqDNA, which is an optimized variant of its ceDNA.

About IZM ICZOOM Group Inc.

ICZOOM Group Inc is engaged in the sale of electronic component products to customers in China. These products are used by small and medium-sized enterprises (SMEs) in the consumer electronic industry, Internet of Things (IoT), automotive electronics, and industrial control segment. In addition to the sales of electronic component products, also provides services to customers such as temporary warehousing, logistic and shipping, and customs clearance and charges them additional service commission fees. The company earns maximum revenue from sale of electronic components.

Share on Social Networks: